<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>phosphatidylethanolamines is_biomarker_for colorectal adenocarcinoma tissue — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>phosphatidylethanolamines</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>colorectal adenocarcinoma tissue</strong>
</div>
<div class="entity-id">CHEBI:16038 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:20%;--color:#ff7f0e"></div>
<div class="stat-row">
  <span>Class: Replicated (2.0)</span>
  <span>Replicated: 3 papers</span>
  <span>Score: 133.47<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 2.0 (Replicated) &times; log&#8322;(3+1) = 4.00<br>Incoming citations: 59 &rarr; score 133.47</div>


<p class="section-label">EVIDENCE CHAIN &middot; 3 sources</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#ff7f0e" title="Replicated"></span><span>Replicated</span><a href="https://doi.org/10.1007/s00216-012-5841-x">10.1007/s00216-012-5841-x</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS289">MTBLS289</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#ff7f0e" title="Replicated"></span><span>Replicated</span><a href="https://doi.org/10.1080/14789450.2020.1757443">10.1080/14789450.2020.1757443</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#ff7f0e" title="Replicated"></span><span>Replicated</span><a href="https://doi.org/10.3390/ijms25147722">10.3390/ijms25147722</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 59 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>30</span><span class="cite-subtotal">&middot; +56.79</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Plasmalogens (PS(P-36:1), PS(P-38:3), PS(P-40:5)) — distinguishes → Colon Cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/fb2804c44224fa03.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Colon Cancer — decreases → Glyceronephosphate O-acyltransferase (GNPAT)</span><span class="cite-claim-weight">+10.00</span><a href="../claim/078a3491e2812d97.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Ether lipids — distinguishes → Colon Cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/b736c0400ebdde6e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Plasma lipid profile — distinguishes → Colon Cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/cc03a1b39972110e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC(18:0/18:1) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8477d23a810774c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PE(18:0/20:4) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bb50e0c283aa54f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bb313c103d3f8b81.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/367abe64d5d037b2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerols — increases → Colorectal cancer tissue</span><span class="cite-claim-weight">+0.79</span><a href="../claim/ca34cc4d74971bd7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bisphenol A — predicts → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/028a1d5bfb7f13f4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 34:0 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6755aed6969a335f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 37:1 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5461904f66dd04a0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine PE 34:2 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.50</span><a href="../claim/467cb1cf8f538733.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerol TG 56:4 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.50</span><a href="../claim/41e53c43b7a04e7e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bisphenol A — causes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7d3063bbbc490a47.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">odd-chain fatty acyl-containing triacylglycerols — distinguishes → colon cancer</span><span class="cite-claim-weight">+4.00</span><a href="../claim/55b1b2efbdcd8b5d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC 44:5 — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/30c5fd9ccfe505fb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC 35:6e — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8ddc19efefc1659b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SM d40:3 — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8e4961dd3a493b4d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipid panel (PC 44:5 + PC 35:6e + SM d40:3) — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7c0a44eef9f07abe.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">differential lipids (top 10) — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d90eba95077dd648.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tongue coating lipid panel (21 lipids) — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/aa324b85cef24509.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tongue coating lipid panel (9 lipids) — distinguishes → colorectal cancer vs colorectal adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/f9aa043bc5e62b6b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">12-HETE — decreases → colorectal tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/dbac13bb3d024a4d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">N-acyl ornithine (NAOrn) — correlates_with → sphingomyelin (SM)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6860cd1deb60b558.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bacteroidetes — is_metabolite_of → N-acyl ornithine (NAOrn)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7cfcbb3a9780f36b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Cholesteryl esters — distinguishes → FOLFOXIRI-resistant SW620 colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a90a4cff6ebc8100.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Hexosylceramide — distinguishes → FOLFOXIRI-resistant HCT116, LS174T, and DLD1 colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bcc4fe98268a8c95.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sphingomyelin — distinguishes → FOLFOXIRI-resistant HCT116, LS174T, and DLD1 colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6816f462d85912b3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">FOLFOXIRI chronic exposure — increases → Sphingomyelin</span><span class="cite-claim-weight">+0.50</span><a href="../claim/efb08c16669d0118.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:3px"></span><span>1</span><span class="cite-subtotal">&middot; +0.40</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">FOLFOXIRI chronic exposure — increases → Hexosylceramide</span><span class="cite-claim-weight">+0.40</span><a href="../claim/cf527ab0501fe579.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:90px"></span><span>27</span><span class="cite-subtotal">&middot; +75.98</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+5.57</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+7.20</span><a href="../claim/6ad1651b9e44eeed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Phosphatidylcholines (PCs) — is_biomarker_for → Colorectal Carcinoma</span><span class="cite-claim-weight">+4.80</span><a href="../claim/4d490d6332335a4a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Phospholipid profile — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/6731a61527be13c8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PS(P-36:1) — is_biomarker_for → Colon Cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/e5580b1247bed017.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PS(P-38:3) — is_biomarker_for → Colon Cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/3b7808708f4549b0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PS(P-40:5) — is_biomarker_for → Colon Cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/9e931b612f647350.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/da12e4ff94bff4d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylglycerol — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5ccf3ca6907853fc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sterol esters — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/2ddf49d0d1512692.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipogenic phenotype (upregulated lipogenesis) — correlates_with → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/fc1a0b488fe38bb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bisphenol A — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ed1d7e2112a84a62.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 34:0 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bd2b1c00049c4695.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 37:1 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/0d3ac63cb558fadd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine PE 34:2 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6dcbfda2c1089a5e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerol TG 56:4 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/dec5c4119bcf8d8a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">sphingolipids — is_biomarker_for → colon cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/19f874501acc5676.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine — is_biomarker_for → colorectal advanced adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/735d077b4e121736.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelin — is_biomarker_for → colorectal advanced adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/4e8c3e1d7977e813.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelin — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/bdaabbf0139a1174.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylethanolamine plasmalogen (PE-P) — decreases → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/d00b5f34608de23d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tongue coating lipids — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/05bc074de4fc6ee3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerols — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/91c7e117aa28d92a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophospholipids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/7be939a27b92bfa4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Unsaturated fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/e0900715a00c585e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — distinguishes → FOLFOXIRI-resistant SW620 colorectal cancer cells</span><span class="cite-claim-weight">+0.60</span><a href="../claim/d3889998afcb28f1.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:3px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">N-acyl ornithine (NAOrn) — correlates_with → ceramide phosphoethanolamine (PE-Cer)</span><span class="cite-claim-weight">+0.30</span><a href="../claim/50a78a9c58734348.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>b159e4d0edb92c50</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:16038">CHEBI:16038</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
